Showing 1 - 8 of 8
An analysis of FDA-approved new molecular entities reveals dynamism in terms of new innovation. An assessment of the first patent for each drug reveals that the pharmaceutical industry, particularly large, established companies in North America, tend to dominate the field. Over the past 10-15...
Persistent link: https://www.econbiz.de/10011193590
Persistent link: https://www.econbiz.de/10012511801
We study how the timing of information disclosure affects the diffusion of codified technical information. On November 29, 2000, the American Inventors Protection Act (AIPA) reduced the default publication time of patents at the United States Patent and Trademark Office (USPTO) to 18 months. We...
Persistent link: https://www.econbiz.de/10012852512
Persistent link: https://www.econbiz.de/10015070188
Persistent link: https://www.econbiz.de/10014372743
Persistent link: https://www.econbiz.de/10003932290
Persistent link: https://www.econbiz.de/10011716637
This paper analyses business-driven innovation in education by looking at education-related patents. It first draws a picture of the challenges for innovation in the formal education sector, which suffers from a poor knowledge ecology: science is hardly linked to core teaching and administrative...
Persistent link: https://www.econbiz.de/10012454937